Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Dr. Kellum was great during the presentation today.
View:
Post by hmmmmmmmm on May 17, 2021 3:49pm

Dr. Kellum was great during the presentation today.

The promising and painful moment was at min 7:56  when Dr. Kellum said- we would be done with the TIGRIS trial by now if it were not for the disrupton caused by COVID...

Seto was also very strong.
Comment by SouthernTierTom on May 17, 2021 4:00pm
At the end of the end I am afraid I have to disagree. They are both wonderfully intelligent gents indeed, but I found both to be "off their game" I wondered why EDTXF didn't simply tell us in the corportate prezzie that the CV19 trial was to be "wrapped up"..TOO bad this had to be shared in our CMO's first public broadcast...Furthermore, I see Dr. Ronco is set to ...more  
Comment by mercedesman on May 17, 2021 4:00pm
Even more painful is the notion that both products (PMX and CRRTs) could have been useful in the war on Covid (due to increased incidence of Sepsis and AKI). Remains to be seen if Covid will be defeated in NA post 2021. But's its clear Sepsis and AKI will, in the future, be at least as prevelent as it was pre-Covid.  Stats will likely show that acute and chronic kidney injury is on the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities